Rare and Genetic Kidney Disease Drug Development Summit
Evvnt Promotion / evvnt
Archivo
30.11.2021 - 02.12.2021 Online
Time: 10:00 am - 5:30 pm
Temas de la conferencia
Marrying unmissable insights from global renal experts, the 1st Rare and Genetic Kidney Disease Drug Development Summit is uniquely positioned to provide you with transformative perspectives from identifying genetic drivers of rare kidney diseases to innovative trial design in small disease populations to accelerate progress of your genetic kidney disease pipeline.
Marrying unmissable insights from global renal experts, the 1st Rare and Genetic Kidney Disease Drug Development Summit is uniquely positioned to provide you with transformative perspectives from identifying genetic drivers of rare kidney diseases to innovative trial design in small disease populations to accelerate progress of your genetic kidney disease pipeline.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/853526-3?pid=4832
Speakers: Alan Glicklich, Chief Medical Officer, Chinook Therapeutics, Alex Bell, Director Kidney Disease Drug Discovery, Ionis Pharmaceuticals and more
Brochure: https://go.evvnt.com/853526-3?pid=4832
Speakers: Alan Glicklich, Chief Medical Officer, Chinook Therapeutics, Alex Bell, Director Kidney Disease Drug Discovery, Ionis Pharmaceuticals and more
Información e inscripción:
https://go.evvnt.com/853526-1?pid=4832
Ms. Emily Birt
Medicina General
Idioma
Inglés
Inglés
Cuota del Congreso
USD 1899.00 - USD 3397.00
USD 1899.00 - USD 3397.00
Los participantes esperaban
1000
1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
